null

Anti-Human CD194 (CCR4) (Mogamulizumab) - HRP Biosimilar (IVMB0422)

SKU:
IVMB0422
Antibody Type:
HRP Biosimilar
Modifications:
HRP-Conjugated
Applications:
IHC
ELISA
Drug Development
Pharmacokinetics
Disease Area:
B-Cell Malignancies
Disease Area:
Immunotherapy
€659

Description

system_update_altDatasheetsystem_update_altMSDS